Literature DB >> 24120892

Systems biology in drug discovery and development.

Ellen L Berg1.   

Abstract

The complexity of human biology makes it challenging to develop safe and effective new medicines. Systems biology omics-based efforts have led to an explosion of high-throughput data and focus is now shifting to the integration of diverse data types to connect molecular and pathway information to predict disease outcomes. Better models of human disease biology, including more integrated network-based models that can accommodate multiple omics data types, as well as more relevant experimental systems, will help predict drug effects in patients, enabling personalized medicine, improvement of the success rate of new drugs in the clinic, and the finding of new uses for existing drugs.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24120892     DOI: 10.1016/j.drudis.2013.10.003

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  23 in total

1.  Repository of proposed pathways and protein-protein interaction networks in age-related macular degeneration.

Authors:  Fran M Pool; Christina Kiel; Luis Serrano; Philip J Luthert
Journal:  NPJ Aging Mech Dis       Date:  2020-01-07

2.  Strategies for efficient numerical implementation of hybrid multi-scale agent-based models to describe biological systems.

Authors:  Nicholas A Cilfone; Denise E Kirschner; Jennifer J Linderman
Journal:  Cell Mol Bioeng       Date:  2015-03       Impact factor: 2.321

3.  Text mining-based in silico drug discovery in oral mucositis caused by high-dose cancer therapy.

Authors:  Jon Kirk; Nirav Shah; Braxton Noll; Craig B Stevens; Marshall Lawler; Farah B Mougeot; Jean-Luc C Mougeot
Journal:  Support Care Cancer       Date:  2018-02-23       Impact factor: 3.603

4.  Systematic synergy modeling: understanding drug synergy from a systems biology perspective.

Authors:  Di Chen; Xi Liu; Yiping Yang; Hongjun Yang; Peng Lu
Journal:  BMC Syst Biol       Date:  2015-09-16

5.  Detection for pathway effect contributing to disease in systems epidemiology with a case-control design.

Authors:  Jiadong Ji; Zhongshang Yuan; Xiaoshuai Zhang; Fangyu Li; Jing Xu; Ying Liu; Hongkai Li; Jia Wang; Fuzhong Xue
Journal:  BMJ Open       Date:  2015-01-16       Impact factor: 2.692

6.  Interindividual variation in gene expression responses and metabolite formation in acetaminophen-exposed primary human hepatocytes.

Authors:  Marlon J A Jetten; Ainhoa Ruiz-Aracama; Maarten L J Coonen; Sandra M Claessen; Marcel H M van Herwijnen; Arjen Lommen; Joost H M van Delft; Ad A C M Peijnenburg; Jos C S Kleinjans
Journal:  Arch Toxicol       Date:  2015-06-24       Impact factor: 5.153

Review 7.  Systems Pharmacology in Small Molecular Drug Discovery.

Authors:  Wei Zhou; Yonghua Wang; Aiping Lu; Ge Zhang
Journal:  Int J Mol Sci       Date:  2016-02-18       Impact factor: 5.923

8.  A human tissue-based functional assay platform to evaluate the immune function impact of small molecule inhibitors that target the immune system.

Authors:  Cristina St Pierre; Jane Guo; John D Shin; Laura W Engstrom; Hyun-Hee Lee; Alan Herbert; Laura Surdi; James Baker; Michael Salmon; Sanjiv Shah; J Michael Ellis; Hani Houshyar; Michael A Crackower; Melanie A Kleinschek; Dallas C Jones; Alexandra Hicks; Dennis M Zaller; Stephen E Alves; Ravisankar A Ramadas
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

Review 9.  Integrative approach in the era of failing drug discovery and development.

Authors:  Keehyun Earm; Yung E Earm
Journal:  Integr Med Res       Date:  2014-09-10

10.  Structural and Functional View of Polypharmacology.

Authors:  Aurelio Moya-García; Tolulope Adeyelu; Felix A Kruger; Natalie L Dawson; Jon G Lees; John P Overington; Christine Orengo; Juan A G Ranea
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.